in Ann Oncol as of November 1, 2009 -- updated monthly
Most-cited rankings are recalculated at the beginning of the month.
Rankings are based on citations to articles on this journal site from articles in HighWire-hosted journals.
| 11. | N. Normanno, M. Campiglio, A. De Luca, G. Somenzi, M. Maiello, F. Ciardiello, L. Gianni, D. S. Salomon, S. Menard | ||
| Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth | |||
|---|---|---|---|
|
Ann Oncol Jan 19, 2002; 13: 65-72.
(In "Breast cancer") |
|||
| 12. | B. Glimelius, K. Ekström, K. Hoffman, W. Graf, P.-O. Sjödén, U. Haglund, C. Svensson, L.-K. Enander, T. Linné, H. Sellsröm, R. Heuman | ||
| Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer | |||
|
Ann Oncol Feb 01, 1997; 8: 163-168.
(In "Original Article") |
|||
| 13. | E. Raymond, S. G. Chaney, A. Taamma, E. Cvitkovic | ||
| Oxaliplatin: A review of preclinical and clinical studies | |||
|
Ann Oncol Oct 01, 1998; 9: 1053-1071.
(In "Reviews") |
|||
| 14. | J. Cassidy, C. Twelves, E. Van Cutsem, P. Hoff, E. Bajetta, M. Boyer, R. Bugat, U. Burger, A. Garin, U. Graeven, J. McKendrick, J. Maroun, J. Marshall, B. Osterwalder, G. Pérez-Manga, R. Rosso, P. Rougier, R. L. Schilsky | ||
| First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin | |||
|
Ann Oncol Apr 01, 2002; 13: 566-575.
(In "Gastrointestinal tumors") |
|||
| 15. | N. L. Berinstein, A. J. Grillo-Lopez, C. A. White, I. Bence-Bruckler, D. Maloney, M. Czuczman, D. Green, J. Rosenberg, P. McLaughlin, D. Shen | ||
| Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma | |||
|
Ann Oncol Sep 01, 1998; 9: 995-1001.
(In "Original Article") |
|||
| [Previous 5 Articles] [Next 5 Articles] | |||